Incorrect storage may reduce semaglutide potency, potentially leading to inadequate blood glucose control and hyperglycaemia
Your clinician will assess whether the reaction is likely related to Ozempic, consider alternative causes, and determine whether treatment modification is necessary
In the SUSTAIN 3, 7, and 10 trials, semaglutide was found to be superior to other GLP-1RAs at lowering glycated hemoglobin and body weight
Its helpful to evaluate these potential contributing factors in consultation with your healthcare provider
In SUSTAIN 6, the cardiovascular outcome trial, 788 (48%) OZEMPIC-treated patients were 65 years of age and over and 157 OZEMPIC-treated patients (9.6%) patients were 75 years of age and over
Gallbladder issues An allergic reaction to semaglutide ingredients is rare but not impossible